ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,241.72
0.68%
Dow Jones
39,935.07
0.20%
Gold vs US Dollar
2,374.25
0.42%
Brent Oil
81.13
-0.50%
Bitcoin
67,272.29
2.26%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
26/07/202411:54PR Newswire (US)Piramal Pharma Limited Announces Consolidated Results for Q1FY25
26/07/202411:53Alliance NewsAlliance NewsKnights Group expands in West Midlands with Thursfields purchaseLSE:KGHKnights Group Holdings Plc
26/07/202411:51Alliance NewsAlliance NewsRecord sees slight increase in quarterly assets under managementLSE:RECRecord Plc
26/07/202411:51PR Newswire (US)GMIF2024 Innovation Summit Invites All to Gather in Shenzhen on September 27
26/07/202411:49Alliance NewsAlliance NewsBabcock reinstates final dividend amid significant profit upliftLSE:BABBabcock International Group Plc
26/07/202411:49PR Newswire (US)Hisense Ignites Sporting Passion with Big Screen Viewing from Paris
26/07/202411:46UK RegulatoryIpsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and Kayfanda® (odevixibat) in Alagille Syndrome, two rare cholestatic liver diseasesEU:IPNIpsen SA
26/07/202411:46UK RegulatoryIpsen reçoit des avis positifs du CHMP pour Iqirvo® (elafibranor) dans la cholangite biliaire primitive et Kayfanda® (odévixibat) dans le syndrome d'Alagille, deux maladies rares du foie cholestatiquesEU:IPNIpsen SA
26/07/202411:46UK RegulatoryIpsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and Kayfanda® (odevixibat) in Alagille Syndrome, two rare cholestatic liver diseasesTG:I7GIpsen SA
26/07/202411:46UK RegulatoryIpsen reçoit des avis positifs du CHMP pour Iqirvo® (elafibranor) dans la cholangite biliaire primitive et Kayfanda® (odévixibat) dans le syndrome d'Alagille, deux maladies rares du foie cholestatiquesTG:I7GIpsen SA
26/07/202411:45Alliance NewsAlliance NewsBrighton Pier reports "disappointing" performance due to poor weatherLSE:PIERBrighton Pier Group Plc (the)
26/07/202411:45UK RegulatoryERRATUM : Chiffre d’affaires du 1er semestre 2024 : 129,9 M€ (+3%)LSE:0NZWAurea Sa
26/07/202411:45UK RegulatoryERRATUM : Chiffre d’affaires du 1er semestre 2024 : 129,9 M€ (+3%)EU:AUREAurea
26/07/202411:45PR Newswire (US)Paints & Coatings Market worth $227.5 billion by 2029 - Exclusive Report by MarketsandMarkets™
26/07/202411:45PR Newswire (US)Paints & Coatings Market worth $227.5 billion by 2029 - Exclusive Report by MarketsandMarkets™
26/07/202411:45PR Newswire (US)Piramal Pharma Limited Announces Consolidated Results for Q1FY25
26/07/202411:44Alliance NewsAlliance NewsIN BRIEF: Molten Ventures launches buyback, agrees new debt facilityLSE:GROWMolten Ventures Plc
26/07/202411:42UK RegulatoryInvesco Global Equity Income Trust Plc - Net Asset Value(s)LSE:IGETInvesco Global Equity Income Trust Plc
26/07/202411:41Alliance NewsAlliance NewsECB says cyber stress test of banks shows need for improvement
26/07/202411:41UK RegulatoryInvesco Asia Trust Plc - Net Asset Value(s)LSE:IATInvesco Asia Trust Plc
26/07/202411:40UK RegulatoryInvesco Perpetual UK Smaller Co's Investment Trust Plc - Net Asset Value(s)LSE:IPUInvesco Perpetual Uk Smaller Companies Investment Trust Plc
26/07/202411:40UK RegulatoryJupiter Green Investment Trust Plc - Net Asset Value(s)LSE:JGCJupiter Green Investment Trust Plc
26/07/202411:39UK RegulatoryInvesco Bond Income Plus Ltd - Net Asset Value(s)LSE:BIPSInvesco Bond Income Plus Limited
26/07/202411:38UK RegulatoryInvesco Investment Trusts - Net Asset Value(s)
26/07/202411:35PR Newswire (US)BE OPEN Art congratulates the winners of the Regional Art Competition in the Middle East
26/07/202411:32PR Newswire (US)BE OPEN Art congratulates the winners of the Regional Art Competition in the Middle East
26/07/202411:31PR Newswire (US)Coagulation Testing Market to Reach USD 6.5 Billion by 2034: Surgical Interventions, Aging Population, and Economic Growth Boost Demand | TMR
26/07/202411:30UK RegulatoryInvitation to Enefit Green investor webinars presenting Q2 2024 interim results
26/07/202411:30PR Newswire (US)On Your Marks: TCL Inspires Greatness This Summer with Athletic Spectacle at Home
26/07/202411:30PR Newswire (US)3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings GuidanceNYSE:MMM3M Company

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
GDR
Genedrive
LSE
PPP
Pennpetro Energy
LSE
SOLG
Solgold
LSE
UKOG
Uk Oil & Gas
LSE
OCDO
Ocado
LSE
SBTX
Skinbiotherapeutics
LSE
BIRD
Blackbird
LSE
POS
Plexus
LSE
NWG
Natwest
LSE
AAZ
Anglo Asian Mining
LSE
EZJ
Easyjet
LSE
EME
Empyrean Energy
LSE
ITM
Itm Power
LSE
INSP
Inspirit Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved